Cargando…
The Sprouty/Spred family as tumor suppressors: Coming of age
The Ras/Raf/ERK pathway is one of the most frequently dysregulated signaling pathways in various cancers. In some such cancers, Ras and Raf are hotspots for mutations, which cause continuous activation of this pathway. However, in some other cancers, it is known that negative regulators of the Ras/R...
Autores principales: | Kawazoe, Tetsuro, Taniguchi, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501019/ https://www.ncbi.nlm.nih.gov/pubmed/30874331 http://dx.doi.org/10.1111/cas.13999 |
Ejemplares similares
-
Sprouty2 and Spred1-2 Proteins Inhibit the Activation of the ERK Pathway Elicited by Cyclopentenone Prostanoids
por: García-Domínguez, Carlota A., et al.
Publicado: (2011) -
S-acylation of Sprouty and SPRED proteins by the S-acyltransferase zDHHC17 involves a novel mode of enzyme–substrate interaction
por: Butler, Liam, et al.
Publicado: (2022) -
Progress in experimental research on SPRED protein family
por: Gong, Jian, et al.
Publicado: (2020) -
Sprouty1 is a candidate tumor suppressor gene in medullary thyroid carcinoma
por: Macià, Anna, et al.
Publicado: (2011) -
Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial–mesenchymal transition and endothelial injury by suppressing MAPK activation
por: Liu, Tian, et al.
Publicado: (2022)